Stocks and Investing
Stocks and Investing
Fri, March 10, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (ZYME) at Strong Buy with Decreased Target to $17 on, Mar 10th, 2023
Yigal Nochomovitz of Citigroup, Maintained "Zymeworks Inc." (ZYME) at Strong Buy with Decreased Target from $21 to $17 on, Mar 10th, 2023.
Yigal has made no other calls on ZYME in the last 4 months.
There are 5 other peers that have a rating on ZYME. Out of the 5 peers that are also analyzing ZYME, 3 agree with Yigal's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Robert Burns of "HC Wainwright & Co." Reiterated at Hold and Held Target at $8 on, Tuesday, January 24th, 2023
- Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Friday, January 20th, 2023
- Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022
These are the ratings of the 2 analyists that currently disagree with Yigal
- Charles Zhou of "Guggenheim" Reiterated at Strong Buy and Held Target at $16 on, Wednesday, March 8th, 2023
- Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022
Contributing Sources